A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.

H Ulrich-Pur; G V Kornek; M Raderer; K Haider; W Kwasny; D Depisch; R Greul; B Schneeweiss; G Krauss; J Funovics

doi:10.1002/1097-0142(20000601)88:11<2505::aid-cncr11>3.0.co;2-e

A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.

Identifier:nobleid.org/w1/20260515/BFEFDF00

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BFEFDF00.svg?ark=w1%2F20260515%2FBFEFDF00)](https://nobleid.org/work/w1/20260515/BFEFDF00)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma.

Identifier:nobleid.org/w1/20260515/BFEFDF00

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BFEFDF00.svg?ark=w1%2F20260515%2FBFEFDF00)](https://nobleid.org/work/w1/20260515/BFEFDF00)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work